Topeka, KS, United States of America

Peter A Parks


Average Co-Inventor Count = 4.2

ph-index = 12

Forward Citations = 556(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter A Parks

Introduction

Peter A Parks is a notable inventor based in Topeka, Kansas. He has made significant contributions to the field of medical technology, particularly in the diagnosis and treatment of Attention Deficit Hyperactivity Disorder (ADHD). With a total of 12 patents to his name, Parks has developed innovative methods that enhance the understanding and management of ADHD.

Latest Patents

Among his latest patents is a method and apparatus for determining ADHD medication dosage and monitoring its effects. This method involves sampling the peripheral skin temperature of an individual during a sensory deprived state to derive data that indicates the level of ADHD manifestation. The effectiveness of the medication is calculated by comparing the data to predetermined threshold values. Another significant patent is a technique for diagnosing ADHD using complementary tests. This method includes sampling peripheral skin temperature data from subjects known to have ADHD and those who do not, ultimately determining threshold values that effectively identify ADHD.

Career Highlights

Peter A Parks has worked with prominent organizations such as Eastman Kodak Company and The McLean Hospital Corporation. His experience in these institutions has contributed to his expertise in developing innovative solutions for ADHD.

Collaborations

Parks has collaborated with notable individuals in his field, including Richard N Blazey and David Lynn Patton. These collaborations have likely enriched his research and development efforts.

Conclusion

Peter A Parks stands out as an influential inventor whose work has the potential to significantly impact the diagnosis and treatment of ADHD. His innovative patents reflect a commitment to improving the lives of individuals affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…